Trial of long-term ketamine for depression underway

A national NHMRC-backed trial will evaluate the controversial S8 drug ketamine as a long-term treatment for patients with severe depression.

Researchers at the University of NSW are to lead a multicentre randomised controlled trial that will evaluate the efficacy of a month of ketamine subcutaneous injections in 200 adults with depression who have not responded to conventional medications.